What was the launch price and annual cost for Vimizim (elosulfase alfa) in 2014?
The provided information does not include Vimizim’s 2014 launch price or its annual cost figure, so I can’t give a reliable number.
If you paste the source text (or share a link) you’re working from, I can extract the exact 2014 launch price and convert it into an annual cost if needed (e.g., based on dosing and price-per-vial).
If you meant “what did it cost per year when it launched in 2014?”
Vimizim is priced based on treatment dose and the drug’s unit price (often described per vial or per unit), so “annual cost” depends on:
- the dosing used in the pricing calculation (mg/kg and frequency),
- the typical patient weight assumed,
- the number of vials needed per infusion cycle,
- whether the figure you saw is based on wholesale acquisition cost, list price, or another benchmark.
Quick clarification so I can give the right number
Which country’s pricing are you asking about (US, UK, EU, etc.) and do you mean:
- launch “list price” in 2014, or
- the “annual treatment cost” commonly quoted by analysts at launch?
Reply with the country and (if you have it) the unit price basis (per vial, per mg, or per infusion), and I’ll compute or confirm the 2014 annual cost.